Znn3bq.jpeg
ÉÇÍ·´óѧº£Ñó¿ÆÑ§½ÓÊܵ÷¼Á
²é¿´: 305  |  »Ø¸´: 2

liruihan

Ìú¸Ëľ³æ (ÕýʽдÊÖ)


[×ÊÔ´] ¡¾×ÊÔ´¡¿Cancer: Predictions in lymphoma

The presence of a specific cell type in people with lymphoma is negatively associated with survival, providing a new biomarker with potential clinical applications (Proc. Natl. Acad. Sci. USA 107, 12747¨C12754).
Jonathan Irish et al. used single-cell profiling in samples of human follicular lymphoma and found a subset of lymphoma cells with defective B cell antigen receptor (BCR) signaling. Jonathan Irish The more of these cells in each tumor, the shorter the overall subject survival. Moreover, these lymphoma cells increased in number as tumors relapsed after chemotherapy. Interestingly, BCR signaling could be reactivated in the defective cells, indicating that BCR signaling was not altogether absent but somehow suppressed.
Mechanistically, tumors with high counts of defective BCR cells had less interleukin-7 signaling in infiltrating T cells, but additional work will be required to understand how these cells emerge and what their downstream effects are.
In addition to representing a potential biomarker, the existence of cells with defective BCR signaling may provide new targets against follicular lymphoma.¡ªJCL
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

liruihan

Ìú¸Ëľ³æ (ÕýʽдÊÖ)


°©Ö¢£ºÁܰÍÁöÖеÄÔ¤²âÒò×Ó
ÁܰÍÁö²¡ÈËÖÐÌØÒìϸ°ûÀàÐ͵ĴæÔÚÓ벡È˵ÄÉú´æ³Ê¸ºÏà¹Ø£¬¸Ã·¢ÏÖ¿ÉÌṩһÖÖеÄÉúÎï±ê¼ÇÎ²¢¾ßÓÐDZÔÚµÄÁÙ´²ÒâÒå¡£
ÔÚÂËÅÝÐÔÁܰÍÁöÑù±¾ÖÐʹÓõ¥Ï¸°û·ÂÐÎÇÐÏ÷¼¼Êõ·¢ÏÖÁËһЩ¾ßÓÐȱÏÝBϸ°û¿¹Ô­ÊÜÌ壨BCR£©ÐźŵÄÁܰÍÁöϸ°û¡£Ã¿¸öÖ×ÁöÖÐÕâЩϸ°ûÔ½¶à£¬²¡È˵ÄÉú´æÆÚÔ½¶Ì¡£¶øÇÒ£¬µ±»¯ÁƺóÖ×Áö¸´·¢Ê±ÕâЩÁܰÍÁöϸ°ûÊýÁ¿ÉÏÔö¼Ó¡£ÁîÈ˸ÐÐËȤµÄÊÇ£¬ÔÚÕâЩȱÏÝϸ°ûÖÐBCRÐźſÉÄÜÖØÐ»£¬ÌáʾBCRÐźŲ»ÊÇÒ»Æðȱ·¦¶øÊÇÓÐЩ±»ÒÖÖÆÁË¡£
»úÖÆÉÏ£¬°éÓнϸßÊýÁ¿È±ÏÝBCRµÄÖ×ÁöÔÚ½þÈóµÄTϸ°ûÖнÏÉÙ±í´ïIL-7Ðźţ¬µ«ÐèÒªÁíÍâµÄ¹¤×÷À´Àí½âÕâЩϸ°ûÊÇÈçºÎ³öÏֵĺÍËüÃǵÄÏÂÓÎЧӦÊÇʲô¡£
³ýÁË´ú±íDZÔÚµÄÉúÎï±ê¼ÇÎïÍ⣬°éÓÐȱÏÝBCRÐźŵÄϸ°û´æÔÚ¿ÉÌṩÂËÅÝÐÔÁܰÍÁöеİе㡣
2Â¥2010-09-14 16:35:17
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

lrj107hn

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)


ÕâÊÇÄÄÀïµÄ×ÊÔ´£¿
3Â¥2010-09-14 18:17:29
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ liruihan µÄÖ÷Ìâ¸üÐÂ
¡î ÎÞÐǼ¶ ¡ï Ò»ÐǼ¶ ¡ï¡ï¡ï ÈýÐǼ¶ ¡ï¡ï¡ï¡ï¡ï ÎåÐǼ¶
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ¿ÒÇëÓÐѧУÊÕÁô +3 ¿Â»´È» 2026-04-12 3/150 2026-04-14 16:25 by ÄæË®³Ë·ç
[¿¼ÑÐ] Çóµ÷¼ÁѧУ +9 ²»»á³ÔÈâ 2026-04-13 9/450 2026-04-14 16:12 by bljnqdcc
[¿¼ÑÐ] 22408 312Çóµ÷¼Á +13 ÃÅ·ÃþÃþ 2026-04-14 13/650 2026-04-14 16:07 by Art1977
[¿¼ÑÐ] 300·ÖÇóµ÷¼Á £¨085501»úеר˶£¬±¾¿ÆÑï´ó£© +9 xu@841019 2026-04-11 10/500 2026-04-14 08:48 by ľľmumu¡«
[¿¼ÑÐ] Çóµ÷¼Á +3 ÎÒ°®¸ßÊý¸ßÊý°®Î 2026-04-12 3/150 2026-04-14 01:00 by Íõ¬Bè±
[¿¼ÑÐ] 272·Ö²ÄÁÏ×ÓÇóµ÷¼Á +41 Loy0361 2026-04-10 53/2650 2026-04-13 14:20 by ÕÅzhihao
[¿¼ÑÐ] 0854µ÷¼Á +10 ³¤¹­°Á 2026-04-11 11/550 2026-04-13 10:38 by wp06
[¿¼ÑÐ] Ò»Ö¾Ô¸»ª¹¤085600 331·Ö +7 ÌìÏÂww 2026-04-09 7/350 2026-04-13 09:01 by lhj2009
[¿¼ÑÐ] µçÆø×¨Ë¶320Çóµ÷¼Á +6 СÂé×Ó111 2026-04-10 6/300 2026-04-12 10:54 by lemon6009
[¿¼ÑÐ] 280Çóµ÷¼Á +7 ÙâÙâÒ¹Ò¹ 2026-04-09 10/500 2026-04-12 00:33 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 283Çóµ÷¼Á 086004¿¼Ó¢¶þÊý¶þ +17 ÄǸöàà×Ó 2026-04-10 18/900 2026-04-11 16:27 by Ã÷Ô´ËʱÓÐ
[¿¼ÑÐ] Çóµ÷¼Á£¬Ò»Ö¾Ô¸´óÁ¬Àí¹¤´óѧ354·Ö +5 ÓêÉùÓàÉú 2026-04-11 6/300 2026-04-11 16:12 by ÓêÉùÓàÉú
[¿¼ÑÐ] 275Çóµ÷¼Á +9 1624447980 2026-04-08 10/500 2026-04-11 10:20 by Delta2012
[¿¼ÑÐ] 368Çóµ÷¼Á +3 17385968172 2026-04-10 3/150 2026-04-10 20:12 by µç×Ӱµ±ë
[¿¼ÑÐ] 314Çóµ÷¼Á +18 xhhdjdjsjks 2026-04-09 19/950 2026-04-10 18:53 by HPUCZ
[¿¼ÑÐ] 282£¬µçÆø¹¤³Ìרҵ£¬Çóµ÷¼Á£¬²»Ìôרҵ +9 jggshjkkm 2026-04-10 9/450 2026-04-10 14:55 by ÄæË®³Ë·ç
[¿¼ÑÐ] Ò»Ö¾Ô¸»¦9£¬326ÉúÎïѧÇóÏà¹Ø×¨Òµµ÷¼Á +4 Áõīī 2026-04-09 4/200 2026-04-10 12:07 by pengliang8036
[¿¼ÑÐ] Çóµ÷¼Á +11 ôæôæÒ»ÊéÉú 2026-04-09 13/650 2026-04-10 10:27 by liuhuiying09
[¿¼ÑÐ] 085501»úеӢ¶þ77×Ü·Ö294Çóµ÷¼Á£¬½ÓÊÜ¿çרҵѧϰ +6 ÊØ·¨¹«ÃñØÁ¼Í 2026-04-08 6/300 2026-04-09 15:55 by wp06
[¿¼ÑÐ] ¶þ´Îµ÷¼ÁÇóÀÏʦÊÕÁô +3 ЦЦԬ 2026-04-08 3/150 2026-04-08 23:50 by ×íÔÚ·çÀï
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û